Head-to-Head: which drug tames facial nerve pain better?
NCT ID NCT07252453
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares carbamazepine and oxcarbazepine, two drugs used to treat trigeminal neuralgia, a condition causing severe facial pain. Researchers will enroll 122 adults aged 18-60 who have had the condition for at least two weeks. They will measure pain relief using a standard pain scale and track side effects like liver problems and dizziness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- carbamazepine and oxcarbazepine
- What this could lead to
- If one drug works better or has fewer side effects, it could become the preferred first-choice treatment for trigeminal neuralgia pain.
- What could go wrong
- This is a small, single-center study comparing two already-approved drugs. The difference may be small, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIGEMINAL NEURALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abbassi Shaheed hospital Facio-Maxillary Department
Karachi, Sindh, 75500, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pain relief showdown: one drug vs. two for facial nerve pain
- New combo therapy aims to calm face pain attacks
- Laser showdown: which light therapy zaps facial pain best?
- Massive study aims to predict brain surgery success
- Magnetic pulses to the brain may ease stubborn nerve pain
- AI and VR join forces to fight severe facial pain